17
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Combined Results of Two Phase Il Studies of Taxol (Paclitaxel) in Patients with Relapsed or Refractory Lymphomas

, , , , , , , , , & show all
Pages 295-304 | Received 04 May 1998, Accepted 11 Nov 1998, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Sercan Kaya & Hasan Hüseyin Dönmez. (2020) Effects of paclitaxel and resveratrol on blood characteristics in rabbits. Biotechnic & Histochemistry 95:3, pages 198-202.
Read now
Sagun Goyal, Eunhye Oak, Jingqin Luo, Amanda F. Cashen, Kenneth Carson, Todd Fehniger, John DiPersio, Nancy L. Bartlett & Nina D. Wagner-Johnston. (2018) Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study. Leukemia & Lymphoma 59:2, pages 357-362.
Read now
Sagar Lonial, Martha Arellano, Donald Hutcherson, Amelia Langston, Christopher Flowers, L. T. Heffner$suffix/text()$suffix/text(), Elliott Winton, Mary Jo Lechowicz & Edmund K. Waller. (2006) Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma. Leukemia & Lymphoma 47:10, pages 2155-2162.
Read now
Brad S. Kahl, Howard H. Bailey, Kyung-Mann Kim, Eileen P. Smith, Nancy Turman, Jamie Smith, Jae Werndli, James McGovern, Alcee Jumonville, Eliot C. Williams & Walter L. Longo. (2005) Phase II Study of Weekly Low-Dose Paclitaxel for Relapsed and Refractory Non-Hodgkin's Lymphoma: A Wisconsin Oncology Network Study. Cancer Investigation 23:1, pages 13-18.
Read now
Murray S. Webb, David L. Saltman, Joseph M. Connors & James H. Goldie. (2002) A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 43:5, pages 975-982.
Read now

Articles from other publishers (5)

F. Bompaire, O. Aupee, D. Ricard & D. Psimaras. (2017) Complications neurologiques centrales des traitements anticancéreux, ce que le réanimateur doit savoirCentral nervous system complications of anticancer treatments. Médecine Intensive Réanimation.
Crossref
E. PETER BOSCH, THOMAS M. HABERMANN & AYALEW TEFFERI. 2005. Peripheral Neuropathy. Peripheral Neuropathy 2489 2503 .
Ali R. Jazirehi & Benjamin Bonavida. (2004) Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Molecular Cancer Therapeutics 3:1, pages 71-84.
Crossref
Ralph J. Hauke & James O. Armitage. (2000) Treatment of non-Hodgkin lymphoma. Current Opinion in Oncology 12:5, pages 412-418.
Crossref
A. Pinto, V. Zagonel, V. Gattei & P. Carde. 2000. Progress in Anti-Cancer Chemotherapy. Progress in Anti-Cancer Chemotherapy 111 131 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.